2014
DOI: 10.1007/s13197-014-1525-1
|View full text |Cite
|
Sign up to set email alerts
|

Application of a molecular beacon based real-time isothermal amplification (MBRTIA) technology for simultaneous detection of Bacillus cereus and Staphylococcus aureus

Abstract: A multiplex real-time isothermal amplification assay was developed using molecular beacons for the detection of Bacillus cereus and Staphylococcus aureus by targeting four important virulence genes. A correlation between targeting highly accessible DNA sequences and isothermal amplification based molecular beacon efficiency and sensitivity was demonstrated using phi(Φ)29 DNA polymerase at a constant isothermal temperature of 30°C. It was very selective and consistently detected down to 10 1 copies of DNA. The … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2016
2016
2023
2023

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 15 publications
0
1
0
Order By: Relevance
“…Bioinformatics information gleaned from the human genome project can also provide valuable information about possible health risk factors [5]. In addition to clinical applications, nucleic acid assays have also expanded to fields such as food and beverage testing [6, 7], forensics [8, 9], and quality control in personal care products production [10]. In general, each of these applications relies upon gene amplification technology, often PCR, to first increase the total number of targets to detectable levels and then either simultaneously detect those molecular targets via “real time” fluorescence methods or at the completion of the amplification process by “end point” analysis of the resulting amplicons using DNA arrays.…”
Section: Introductionmentioning
confidence: 99%
“…Bioinformatics information gleaned from the human genome project can also provide valuable information about possible health risk factors [5]. In addition to clinical applications, nucleic acid assays have also expanded to fields such as food and beverage testing [6, 7], forensics [8, 9], and quality control in personal care products production [10]. In general, each of these applications relies upon gene amplification technology, often PCR, to first increase the total number of targets to detectable levels and then either simultaneously detect those molecular targets via “real time” fluorescence methods or at the completion of the amplification process by “end point” analysis of the resulting amplicons using DNA arrays.…”
Section: Introductionmentioning
confidence: 99%